Best case scenario, Semaglutide can garner $500 million sales in FY27, HSBC said. It added that Dr Reddy's will be among the ...

The company's net interest income (NII) surged 33 per cent to Rs 887 crore from Rs 665 crore in the corresponding quarter of ...

Results: For the June quarter, Infosys reported a net profit of ₹6,921 crore, which was higher than CNBC-TV18 poll estimate ...

Persistent Systems reported a 9.8% year-on-year increase in consolidated net profit to ₹4,249.36 million for the quarter ...

Coming off a strong end to 2024, Q1 2025 exhibited the seasonal impacts normally expected. Gross collections were down 2.4 ...

The country's biggest home loan financier by market value reported a profit of ₹583 crore ($67.50 million) for the three ...

Dr Reddy's Laboratories reported a 1.4% increase in consolidated net profit to ₹1,409 crore for Q1FY26, compared to ₹1,392 ...

Infosys Q1 FY26 consolidated net profit rose 8.7 percent year-on-year to Rs 6,921 crore, beating Street expectations. India's second largest IT firm's fiscal first quarter revenue expanded 7.5 percent ...

Shares of Syngene closed 0.70% higher at Rs 680.75 apiece on the NSE, compared to a 0.63% rise in the benchmark Nifty. The ...

The results matched Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for earnings of 19 cents per share. The business consulting services ...

South African clothing retailer Mr Price said on Wednesday its retail sales increased by 6.3%, with comparable store sales ...

United Breweries, India's largest beer maker, reported a nearly 6% rise in quarterly profit on Tuesday, benefiting from lower ...